about
Targeting microRNAs in cancer: rationale, strategies and challenges.MicroRNA signatures of stem cells.Inhibition of porcine reproductive and respiratory syndrome virus replication in vitro using DNA-based short antisense oligonucleotides.Controlled delivery of antisense oligonucleotides: a brief review of current strategies.Making sense of therapeutics using antisense technology.Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.Tissue engineering and microRNAs: future perspectives in regenerative medicine.
P2860
Q34141089-F99725FC-83EB-445C-8D57-1AA79D147B87Q35532133-16E36F26-1DFC-40CD-95E2-03E69A756826Q35743375-CCA575EA-9037-4307-B8D6-1535A1A23F2DQ37529859-7FAC3266-CDE2-43B3-9B17-27FF57D66DD2Q38014478-8A6C4452-8B07-4906-A63A-B5BE559E0E2DQ38037048-50807A68-884A-4D27-A7E9-A756C33D25FDQ38552026-706E42F0-EB1A-4C85-BF32-8423D7503A20
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Design and development of antisense drugs.
@en
type
label
Design and development of antisense drugs.
@en
prefLabel
Design and development of antisense drugs.
@en
P2860
P1476
Design and development of antisense drugs
@en
P2093
Ipsita Roy
P2860
P304
P356
10.1517/17460441.3.10.1189
P407
P577
2008-10-01T00:00:00Z